Pretreatment With Valproate Prior to Immunotherapy Targeting Cluster of Differentiation Antigen 20 in Chronic Lymphocytic Leukemia
Condition(s):Chronic Lymphocytic LeukemiaLast Updated:March 3, 2017Completed
Hide Studies Not Open or Pending
Condition(s):Chronic Lymphocytic LeukemiaLast Updated:March 3, 2017Completed
Condition(s):Recurrent Adult Diffuse Large Cell Lymphoma; Recurrent Grade 1 Follicular Lymphoma; Recurrent Grade 2 Follicular Lymphoma; Recurrent Grade 3 Follicular Lymphoma; Recurrent Mantle Cell LymphomaLast Updated:July 30, 2014Terminated
Condition(s):Lymphoma, Non-Hodgkin; Lymphoma, Low-GradeLast Updated:August 23, 2023Completed
Condition(s):Stage III Melanoma; Stage IV MelanomaLast Updated:October 6, 2015Completed
Condition(s):Primary Membranous NephropathyLast Updated:January 12, 2024Recruiting
Condition(s):CD19 Positive; CD20 Positive; Recurrent Chronic Lymphocytic Leukemia; Recurrent Diffuse Large B-Cell Lymphoma; Recurrent Follicular Lymphoma; Recurrent Mantle Cell Lymphoma; Recurrent Primary Mediastinal (Thymic) Large B-Cell Cell Lymphoma; Recurrent Small Lymphocytic Lymphoma; Refractory Chronic Lymphocytic Leukemia; Refractory Diffuse Large B-Cell Lymphoma; Refractory Follicular Lymphoma; Refractory Mantle Cell Lymphoma; Refractory Primary Mediastinal (Thymic) Large B-Cell Cell Lymphoma; Refractory Small Lymphocytic LymphomaLast Updated:October 6, 2023Recruiting
Condition(s):CD20+ Aggressive Lymphoma, Mantle Cell LymphomaLast Updated:May 13, 2016Unknown status
Condition(s):Diffuse Large B Cell LymphomaLast Updated:May 16, 2016Unknown status
Condition(s):Systemic Lupus Erythematosus (SLE); Immune-Mediated Necrotizing Myopathy; Neuromyelitis Optica Spectrum Disorders; Multiple Sclerosis-Relapsing-RemittingLast Updated:March 26, 2024Recruiting
Condition(s):Large B-cell Lymphoma; DLBCL – Diffuse Large B Cell LymphomaLast Updated:December 19, 2023Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.